跳至主要内容
临床试验/JPRN-UMIN000022592
JPRN-UMIN000022592已完成未知

Evaluation of early prediction using 18F-FDG PET/CT for patients with Iodine-131 refractory differentiated thyroid carcinoma treated with lenvatinib - Early Prediction using 18F-FDG PET/CT for patients with differentiated thyroid carcinoma treated with lenvatinib

Department of Medical Oncology, Hokkaido University Graduate School of Medicine0 个研究点目标入组 22 人开始时间: 2016年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Medullary or undifferentiated thyroid carcinoma 2) Ever treated with chemotherapy 3) Double cancer 4) Poor physical status 5) Severe complication 6) Fasting blood glucose over 150 mg/dl 7) Brain metastasis or vascular thrombus requiring treatment 8) Inappropriate to perform 18F-FDG PET/CT or CT due to complications 9) Pregnanant or nursing woman 10) Other inappropriate patients judged byinvestigators

研究者

发起方
Department of Medical Oncology, Hokkaido University Graduate School of Medicine

相似试验